Spain Computed Tomography Market Size

Spain Computed Tomography Market Analysis

The Spain Computed Tomography Market size is estimated at USD 201.59 million in 2024, and is expected to reach USD 263.47 million by 2029, growing at a CAGR of 5.5% during the forecast period (2024-2029).

The COVID-19 pandemic has a significant impact on the computed tomography market in Spain which was majorly due to the restrictions on non-essential procedures. This resulted in less utilization of CT scans for non-emergency diagnostic applications. However, CT scans were used to a certain extent in diagnosing coronavirus infection in the lungs. With the increasing Spanish population falling prey to COVID-19, there was significant demand for chest CT scans in the country which helped the market keep a steady pace during the pandemic. Moreover, as per the data published by Organization for Economic Co-operation and Development, the mean waiting times for specialist assessment for hip replacement in Spain increased from 146.7 days in the year 2019 to 153.6 days in the year 2020. Similarly, for knee replacement procedures in the country, the mean waiting time surged to 207.5 days in 2020 from 190.6 in 2019. Such growing waiting times have delayed the treatment procedures and early diagnosis of the conditions. However, as computed tomography imaging can help in the efficient analysis of knee or hip scans, the demand for computed tomography imaging across medical facilities in Spain is anticipated to increase in the post-pandemic phase.

The major factors attributing to the growth of Spain's computed tomography market are the increasing incidence of orthopedic diseases, dental and cardiovascular surgeries, and cancer. In addition, rising technological advancements coupled with the increasing spectrum of applications of these devices are propelling their demand in the country.

There has been an increasing investment in the diagnostic imaging sector in Spain which is acting as a beneficial factor for the computed tomography market. For instance, in July 2021, Quibim, a Spanish company involved in healthcare imaging, participated in a EUR 7.5 million High Sensitivity Molecular Imaging project IMAS (Imagen Molecular de Alta Sensibilidad) to build an innovative total-body PET/CT scanner for simultaneous whole-body imaging in a Temporary Business Association (TBA) backed by GE Healthcare experts. Thus, the increasing investments in the country within the concerned market will drive the market during the forecast period.